Published in Support Care Cancer on September 01, 1995
Trends in Tracheostomy for Mechanically Ventilated Patients in the United States, 1993-2012. Am J Respir Crit Care Med (2015) 1.53
High resource utilization does not affect mortality in acute respiratory failure patients managed with tracheostomy. Respir Care (2013) 1.07
Hospital Variation in Early Tracheostomy in the United States: A Population-Based Study. Crit Care Med (2016) 0.80
Leucopenia is an independent predictor in cancer patients requiring invasive mechanical ventilation: a prognostic factor analysis in a series of 168 patients. Support Care Cancer (2003) 0.80
Tracheostomy in Pediatric Intensive Care Unit: When and Where? Iran J Pediatr (2016) 0.75
Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA (2001) 5.55
Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie. N Engl J Med (1998) 4.93
ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr (2006) 4.06
Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie. Br J Surg (1997) 2.18
Sequential sorafenib and sunitinib for renal cell carcinoma. J Urol (2009) 2.12
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol (2010) 2.11
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie. Ann Oncol (2002) 2.03
Benefit of cytoreductive nephrectomy in metastatic RCC: do we learn from retrospective studies and small prospective studies? Ann Oncol (2011) 2.03
Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol (1988) 2.00
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer (2001) 1.92
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol (2010) 1.91
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med (1998) 1.89
Intermittent vascular exclusion of the liver (without vena cava clamping) during major hepatectomy. Br J Surg (1995) 1.88
Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet (1999) 1.83
Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol (1997) 1.77
Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol (1994) 1.77
Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol (2001) 1.68
Influence of a defunctioning stoma on leakage rates after low colorectal anastomosis and colonic J pouch-anal anastomosis. Br J Surg (1998) 1.67
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. Ann Oncol (2010) 1.65
Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial. Br J Cancer (2013) 1.65
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features. Ann Oncol (2009) 1.57
Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin Microbiol Infect (2005) 1.56
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol (2002) 1.55
Diagnostic value of serum IL-6 level in monoclonal gammopathies. Br J Haematol (1995) 1.43
Heat and moisture exchanger vs heated humidifier during long-term mechanical ventilation. A prospective randomized study. Chest (1991) 1.43
Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol (1998) 1.42
Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols. J Nucl Med (1994) 1.41
[What are the real indications for hepatectomies in metastases of colorectal origin?]. Gastroenterol Clin Biol (1998) 1.39
High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity. Ann Oncol (2007) 1.35
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings. Ann Oncol (2011) 1.34
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis (1988) 1.26
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma. Br J Cancer (2013) 1.24
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21
Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood (1990) 1.20
Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. Am J Physiol Renal Physiol (2000) 1.19
Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer (1998) 1.18
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma. Ann Oncol (2008) 1.18
Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib. Ann Oncol (2009) 1.15
Pseudoepidemic of aspergillosis after development of pulmonary infiltrates in a group of bone marrow transplant patients. J Clin Microbiol (1987) 1.14
Value of semiquantitative cultures of blood drawn through catheter hubs for estimating the risk of catheter tip colonization in cancer patients. J Clin Microbiol (1988) 1.13
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer Res (1992) 1.13
Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatology (1983) 1.11
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer (2010) 1.10
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib. Br J Cancer (2009) 1.09
Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine. Intensive Care Med (1998) 1.09
Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unit. Infect Control Hosp Epidemiol (1990) 1.07
[Standards, options and recommendations: nutritional support in palliative or terminal care of adult patients with progressive cancer]. Bull Cancer (2001) 1.07
How to adjust desired drug release patterns from ethylcellulose-coated dosage forms. J Control Release (2007) 1.06
Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin Infect Dis (2002) 1.04
Exosomes for cancer immunotherapy. Ann Oncol (2004) 1.03
Prevalence of obesity: a comparative survey in France, the United Kingdom and the United States. Int J Obes Relat Metab Disord (1992) 0.99
Upregulation of alveolar epithelial fluid transport after subacute lung injury in rats from bleomycin. Am J Physiol (1998) 0.98
Incidence of brain metastases in renal cell carcinoma treated with sorafenib. Ann Oncol (2009) 0.98
Fiberoptic bronchoscopy in ventilated patients. Evaluation of cardiopulmonary risk under midazolam sedation. Chest (1990) 0.98
Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study. J Clin Oncol (1996) 0.97
Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients. Clin Exp Immunol (2000) 0.97
Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.96
Severity-of-illness scores for neutropenic cancer patients in an intensive care unit: Which is the best predictor? Do multiple assessment times improve the predictive value? Crit Care Med (1998) 0.96
Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. Br J Cancer (2011) 0.96
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study. HIV Med (2008) 0.95
Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol (2006) 0.94
Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis. Oncology (2002) 0.94
Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer (1997) 0.94
Value of gram stain examination of lower respiratory tract secretions for early diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med (2000) 0.94
Long-term functional outcome after low anterior resection: comparison of low colorectal anastomosis and colonic J-pouch-anal anastomosis. Dis Colon Rectum (1998) 0.94
Survival after neuroAIDS: association with antiretroviral CNS Penetration-Effectiveness score. Neurology (2011) 0.93
The postchemotherapy PSA surge syndrome. Ann Oncol (2008) 0.92
Adenocarcinoma of the rete testis. World J Urol (1996) 0.92
Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis. Br J Cancer (2013) 0.91
Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J Infect (1999) 0.91
Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors. Support Care Cancer (2003) 0.91
Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosis. Lab Invest (1999) 0.90
Transforming growth factor-alpha increases alveolar liquid clearance in anesthetized ventilated rats. Am J Physiol (1996) 0.90
Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma. Oncogene (2011) 0.90
Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. Blood (2000) 0.89
Ethanol-resistant polymeric film coatings for controlled drug delivery. J Control Release (2013) 0.89
Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig (2000) 0.89
Isospora belli infection in a patient with non-Hodgkin's lymphoma. Clin Microbiol Infect (2003) 0.89
Triple combination of bevacizumab, gemcitabine and platinum salt in metastatic collecting duct carcinoma. Ann Oncol (2013) 0.88
Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients. Gene Ther (2003) 0.88